DK3863647T3 - Behandling af ondartet knoglesmerte med pentosanpolysulfat - Google Patents
Behandling af ondartet knoglesmerte med pentosanpolysulfat Download PDFInfo
- Publication number
- DK3863647T3 DK3863647T3 DK19871048.5T DK19871048T DK3863647T3 DK 3863647 T3 DK3863647 T3 DK 3863647T3 DK 19871048 T DK19871048 T DK 19871048T DK 3863647 T3 DK3863647 T3 DK 3863647T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- bone pain
- malignant bone
- pentosane polysulfate
- pentosane
- Prior art date
Links
- 206010006002 Bone pain Diseases 0.000 title 1
- JCSJTDYCNQHPRJ-MMDFAQQLSA-N beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-beta-D-Xylp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)OC2)O)OC1 JCSJTDYCNQHPRJ-MMDFAQQLSA-N 0.000 title 1
- 230000003211 malignant effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018903820A AU2018903820A0 (en) | 2018-10-10 | Treatment of pain with polysulfated polysaccharides | |
| AU2019900326A AU2019900326A0 (en) | 2019-02-04 | Treatment of pain with polysulfated polysaccharides | |
| AU2019903556A AU2019903556A0 (en) | 2019-09-24 | Treatment of pain with polysulfated polysaccharides | |
| PCT/AU2019/051094 WO2020073089A1 (en) | 2018-10-10 | 2019-10-10 | Treatment of pain with polysulfated polysaccharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3863647T3 true DK3863647T3 (da) | 2024-04-29 |
Family
ID=70163626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19871048.5T DK3863647T3 (da) | 2018-10-10 | 2019-10-10 | Behandling af ondartet knoglesmerte med pentosanpolysulfat |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11752169B2 (da) |
| EP (2) | EP3863647B1 (da) |
| JP (1) | JP2022512662A (da) |
| KR (1) | KR20210075133A (da) |
| CN (1) | CN112888442A (da) |
| AU (2) | AU2019357946A1 (da) |
| CA (1) | CA3115348A1 (da) |
| DK (1) | DK3863647T3 (da) |
| FI (1) | FI3863647T3 (da) |
| PT (1) | PT3863647T (da) |
| SG (1) | SG11202103319SA (da) |
| WO (1) | WO2020073089A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240026036A1 (en) * | 2020-09-28 | 2024-01-25 | Medimmune Limited | Compounds and methods for treating pain |
| CN115105525A (zh) * | 2022-08-06 | 2022-09-27 | 海立智生物技术(上海)有限公司 | 岩藻多糖及其组合物在缓解偏头痛中的应用 |
| CN115120610B (zh) * | 2022-08-11 | 2023-05-26 | 海立智生物技术(上海)有限公司 | 岩藻多糖及其组合物在治疗多动症中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6593310B1 (en) * | 2000-11-21 | 2003-07-15 | Arthropharm Pty. Ltd. | Treatment of osteoporosis |
| US20080076723A1 (en) * | 2006-09-27 | 2008-03-27 | Sylvan Pharmaceuticals Pty Ltd. | Inhibition of cathepsin K activity and the treatment and prevention of disease |
| AU2008255565B2 (en) | 2007-05-31 | 2013-10-24 | Paradigm Biopharmaceuticals Ltd | Sulphated xylans for treatment or prophylaxis of respiratory diseases |
| TWI520740B (zh) * | 2011-02-02 | 2016-02-11 | 模範健康科技私人企業有限公司 | 利用多硫酸化多醣之骨髓水腫（水腫）的治療 |
| ES2664844T3 (es) * | 2011-06-20 | 2018-04-23 | Mount Sinai School Of Medicine | Tratamiento dirigido contra TNF para las mucopolisacaridosis y otros trastornos lisosómicos |
-
2019
- 2019-10-10 SG SG11202103319SA patent/SG11202103319SA/en unknown
- 2019-10-10 DK DK19871048.5T patent/DK3863647T3/da active
- 2019-10-10 EP EP19871048.5A patent/EP3863647B1/en active Active
- 2019-10-10 CA CA3115348A patent/CA3115348A1/en active Pending
- 2019-10-10 AU AU2019357946A patent/AU2019357946A1/en not_active Abandoned
- 2019-10-10 FI FIEP19871048.5T patent/FI3863647T3/fi active
- 2019-10-10 WO PCT/AU2019/051094 patent/WO2020073089A1/en active Application Filing
- 2019-10-10 JP JP2021519756A patent/JP2022512662A/ja active Pending
- 2019-10-10 PT PT198710485T patent/PT3863647T/pt unknown
- 2019-10-10 US US17/284,071 patent/US11752169B2/en active Active
- 2019-10-10 EP EP24156894.8A patent/EP4344740A2/en active Pending
- 2019-10-10 CN CN201980067043.2A patent/CN112888442A/zh active Pending
- 2019-10-10 KR KR1020217013752A patent/KR20210075133A/ko unknown
-
2022
- 2022-10-25 AU AU2022259716A patent/AU2022259716B2/en active Active
-
2023
- 2023-07-20 US US18/224,492 patent/US20240066050A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3115348A1 (en) | 2020-04-16 |
| EP3863647B1 (en) | 2024-02-14 |
| JP2022512662A (ja) | 2022-02-07 |
| US20240066050A1 (en) | 2024-02-29 |
| KR20210075133A (ko) | 2021-06-22 |
| EP4344740A2 (en) | 2024-04-03 |
| US20210330695A1 (en) | 2021-10-28 |
| SG11202103319SA (en) | 2021-04-29 |
| AU2022259716B2 (en) | 2024-05-02 |
| US11752169B2 (en) | 2023-09-12 |
| AU2022259716A1 (en) | 2022-12-01 |
| EP3863647A4 (en) | 2022-06-29 |
| CN112888442A (zh) | 2021-06-01 |
| WO2020073089A1 (en) | 2020-04-16 |
| FI3863647T3 (fi) | 2024-03-01 |
| EP3863647A1 (en) | 2021-08-18 |
| AU2019357946A1 (en) | 2021-05-27 |
| PT3863647T (pt) | 2024-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3554631T3 (da) | Behandling af patienter med ttfields med elektrodepositionerne optimeret under anvendelse af deformerbare skabeloner | |
| DK3431105T3 (da) | Medicinsk sammensætning til behandling af cancer | |
| DK3673080T3 (da) | Antisense-oligomerer til behandling af lidelser og sygdomme | |
| MA47310A (fr) | Combinaisons de cabozantinib et d'atzolizumab pour traiter le cancer | |
| DK3347030T3 (da) | Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme | |
| DK3631454T3 (da) | Behandling af lag-3 positive tumorer | |
| GB201804514D0 (en) | Treatment of pyroptosis | |
| DK3458052T3 (da) | Kombinationsbehandling af cancer | |
| DK3863647T3 (da) | Behandling af ondartet knoglesmerte med pentosanpolysulfat | |
| DK3641888T3 (da) | Plasminogenbehandling af tilstande forbundet med pai-1-overekspression | |
| DK3166628T3 (da) | Terapeutisk anvendelse af knoglemorfogenetiske proteiner | |
| DK3773558T3 (da) | Kombinationsbehandling af artritisk sygdom | |
| DK3897672T5 (da) | Hbv kombinationsbehandling | |
| MA53553A (fr) | Traitement post-chirurgical de la douleur | |
| DK3525774T3 (da) | Lasofoxifen behandling af er+ brystcancer | |
| DK3722291T3 (da) | Indolinonforbindelser og deres anvendelse i behandlingen af fibrotiske sygdomme | |
| DK3368058T3 (da) | Fremgangsmåde til induktion af kardiocytproliferation og behandling af hjertesygdomme | |
| SG11202011117VA (en) | Treatment of cancer | |
| DK3585808T3 (da) | Modificerede serpiner til behandlingen af bradykinin formidlet sygdom | |
| DK3403674T3 (da) | Farmaceutiske sammensætninger til behandling af smerte | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| DK3532072T3 (da) | Behandling af glaukom | |
| DK3352857T3 (da) | Syd985 behandling af t-dm1 refraktære kræftpatienter | |
| DK3638370T3 (da) | Behandling af migræne med acetyl-leucin | |
| GB201805100D0 (en) | Treatment of sarcopenic diseases |